Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
3.060
-0.150 (-4.67%)
At close: Jul 25, 2025, 4:00 PM
2.960
-0.100 (-3.27%)
After-hours: Jul 25, 2025, 5:57 PM EDT

Aptevo Therapeutics Stock Forecast

APVO's stock price has decreased by -98.98% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Aptevo Therapeutics stock has a target of 5920, which predicts a 193364.05% increase from the current stock price of 3.06.

Price Target: $5920 (+193364.05%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$5,920$5,920$5,920$5,920
Change+193364.1%+193364.1%+193364.1%+193364.1%
* Price targets were last updated on Sep 23, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Aptevo Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '24May '24Jun '24Jul '24Aug '24Sep '24
Strong Buy111111
Buy111110
Hold000000
Sell000000
Strong Sell000000
Total222221

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Roth MKM
Roth MKM
Strong Buy
Maintains
$11,100$5,920
Strong BuyMaintains$11,100$5,920+193,364.05%Sep 23, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$2,246,640$651,200
BuyMaintains$2,246,640$651,200+21,280,945.75%May 13, 2022
Roth Capital
Roth Capital
Strong Buy
Maintains
$2,083,840$1,628,000
Strong BuyMaintains$2,083,840$1,628,000+53,202,514.38%May 28, 2021
Piper Sandler
Piper Sandler
Buy
Maintains
$1,041,920$2,246,640
BuyMaintains$1,041,920$2,246,640+73,419,507.84%Nov 11, 2020
Roth Capital
Roth Capital
Strong Buy
Initiates
$5,470,080
Strong BuyInitiates$5,470,080+178,760,684.31%Apr 11, 2018
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-323.14
from -1.75K
EPS Next Year
-295.60
from -323.14
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
4.31M12.29M3.11M----6.87M
Revenue Growth
-185.26%-74.67%-----
EPS
-----1,747.66-323.14-295.60-204.61
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a7.1M
Avgn/an/a6.9M
Lown/an/a6.6M

Revenue Growth

Revenue Growth20252026202720282029
High---
Avg---
Low---

EPS Forecast

EPS20252026202720282029
High-332.64-304.29-210.63
Avg-323.14-295.60-204.61
Low-310.46-284.00-196.59

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.